You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
UBS lowered the target price of Ping An Good Doctor (01833.HK) to 20 yuan, rating "Neutral"
UBS issued a rating report that downgraded the revenue forecast of Ping an good Doctor (01833.HK) in 2023-25, reflecting that the company may complete non-core business adjustments in the near future. The bank said its revenue bottomed out in the first half of this year and is expected to continue to grow every quarter, benefiting from the business strategy of integrated financial business users (F-side) and enterprise customers (B-side). The bank said that with the transformation of the company's strategy, the company is expected to be less vulnerable to factors such as a macroeconomic slowdown and tighter regulation in the near future. With the company's further penetration into Ping an Group's high-value customer base, revenue is expected to return to a low ten-figure income next year, and gross profit margin will rise slightly to break even in 2024-25. The bank lowered its target price for safe and good doctors from 23 yuan to 20 yuan, maintaining its "neutral" rating. (ca/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account